(Q41514494)

2 October 2017

1 reference

title

Established antiepileptic drugs (English)

1 reference

2 October 2017

M J Brodie

1

1 reference

PubMed ID

9203243

2 October 2017

M A Dichter

series ordinal

2

1 reference

2 October 2017

1 June 1997

1 reference

Seizure-European Journal of Epilepsy

2 October 2017

1 reference

2 October 2017

6

1 reference

2 October 2017

3

1 reference

2 October 2017

159-174

1 reference

Epidemiology, classification, natural history, and genetics of epilepsy

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Prevalence of epilepsy in Rochester, Minnesota: 1940-1980.

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

The natural history of untreated epilepsy in a rural community in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Changing view of prognosis of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Does the number of seizures before treatment influence ease of control or remission of childhood epilepsy? Not if the number is 10 or less

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Diagnosis of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

1 reference

7 January 2021

A prospective study on sudden unexpected death in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Seizure recurrence after a 1st unprovoked seizure: an extended follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Early treatment of a single generalized tonic-clonic seizure to prevent recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

New antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Absence seizures and carbamazepine in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Rapid tolerance to acute psychomotor impairment with carbamazepine in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Monotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Serum anticonvulsant concentrations and the risk of drug induced skin eruptions

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Drug interactions in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Use of oral contraceptives by women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Lamotrigine--an update

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Lithium-carbamazepine neurotoxicity and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

The action of phenytoin on a composite electrical-chemical synapse in the lamprey spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Depression of synaptic transmission by diphenylhydantoin

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Pharmacokinetic optimisation of anticonvulsant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Cerebellar atrophy in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Clinically relevant anti-epileptic drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Drug interactions that matter. A critical reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Antiepileptic drug mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Valproate-induced coma with ketosis and carnitine insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Valproic acid hepatic fatalities: a retrospective review

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Drug interactions with valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Clinical valproate toxicity induced by acetylsalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Rational use of antiepileptic drug levels

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Antiepileptic drugs. A review of clinically significant drug interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Factors relating to dramatic response to clobazam therapy in refractory epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Intermittent clobazam for catamenial epilepsy: tolerance avoided

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Current status of the 1,4- and 1,5-benzodiazepines in the treatment of epilepsy: the place of clobazam

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Clinical effects and plasma concentrations of long-term clonazepam monotherapy in previously untreated epileptics

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Discontinuation of clonazepam after long-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Management of epilepsy during pregnancy and lactation

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Dual effects of carbamazepine-phenytoin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Five years of anticonvulsant monitoring on site at the epilepsy clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Effects of Discontinuation of Phenytoin, Carbamazepine, and Valproate on Concomitant Antiepileptic Medication

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Cognitive Adverse Effects of Antiepileptic Drugs : Incidence, Mechanisms and Therapeutic Implications

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Psychosocial sequelae of epilepsy: the role of associated cerebral pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Psychomotor impairment and anticonvulsant therapy in adult epileptic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Differential diagnosis in pseudoepileptic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Nonepileptic seizures and childhood sexual and physical abuse

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Valproate-ethosuximide combination therapy for refractory absence seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Removal of sedative-hypnotic antiepileptic drugs from the regimens of patients with intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

1 reference

7 January 2021

If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? A randomized prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Serum phenytoin concentration and clinical response in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Therapeutic drug monitoring improves seizure control and reduces anticonvulsant side-effects in patients with refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Guidelines for therapeutic monitoring on antiepileptic drugs. Commission on Antiepileptic Drugs, International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine)

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

1 reference

7 January 2021

Discontinuing antiepileptic medication in children with epilepsy after two years without seizures. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Prognosis after therapy discontinuation in children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Discontinuing antiepileptic drugs in children with epilepsy: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Phenytoin and postoperative epilepsy. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Prophylactic phenytoin in severe head injuries

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

Intractable seizures: long-term follow-up after prolonged inpatient treatment in an epilepsy unit.

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2897%2980001-5

7 January 2021

10.1016/S1059-1311(97)80001-5

Identifiers

DOI

1 reference

2 October 2017

1 reference

PubMed ID

9203243